Molbio Diagnostics (MOLBIO) — Financial Results

1 Financial Results 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Q1 FY27 revenue rose to ₹411.48 crore with EBITDA turning positive at ₹103.68 crore

🔄 What Changed
Revenue increased from ₹100.5 crore to ₹411.48 crore; EBITDA shifted from loss of ₹14.50 crore to profit of ₹103.68 crore

🔮 What's Next
Management expects FY27 performance to be assessed on a full-year basis due to non-linear quarterly patterns

💡 Investor Takeaway
Shareholders see improved profitability and growth momentum from higher test kit volumes and international expansion

Molbio Diagnostics reported Q1 FY27 total income of ₹411.48 crore, up from ₹100.5 crore in Q1 FY26, driven by higher test kit volumes. EBITDA turned positive at ₹103.68 crore versus a loss of ₹14.50 crore a year earlier, with PAT at ₹52.7 crore compared to a loss of ₹23.9 crore. The company highlighted non-linear quarterly revenue patterns and deferred export orders of approximately [amount context mismatch] crore from Q4 FY26 now recognized in Q1 FY27.

2 Financial Results 🔴 High Importance Neutral 📄 PDF

📢 Key Event
Audio recording of earnings call made available

💡 Investor Takeaway
Shareholders can now access the full audio of the earnings discussion for deeper insight.

Molbio Diagnostics announced that the audio recording of its earnings call for the quarter ended June 30, 2026 is now available on its website, www.molbiodiagnostics.com, following the September 08, 2026 investor meet.

📊 Stock Analysis — MOLBIO ✨ Ask AI About This

About Molbio Diagnostics Ltd (MOLBIO)

Healthcare · Healthcare · Listed on BSE

Market Cap: ₹16,255.48 Cr

View full MOLBIO stock details →

📡 Get AI alerts when MOLBIO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track MOLBIO — Free

💡 Ask AI about this filing

"How will Q4 FY26 export orders impact future revenue?" "What is the revenue contribution from oncology assays?" "When will the Bengaluru R&D facility become operational?"

Ask AI Free →

📊 More MOLBIO filings

See all MOLBIO filings →

🔥 Also filed on 8 September 2026

500357 Rama Paper Mills Ltd Annual Report 514028 Rajkamal Synthetics Ltd Annual Report INDIANORG Futura Polyesters Ltd Financial Results UYFINCORP U. Y. Fincorp Ltd Annual Report APOLLO Apollo Micro Systems Ltd Annual Report 544201 Dindigul Farm Product Ltd Corporate Action

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when MOLBIO files new disclosures

Track MOLBIO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track MOLBIO — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

Molbio Diagnostics Ltd (MOLBIO) — Financial Results | 8 September 2026(2 announcements)

About Molbio Diagnostics Ltd (MOLBIO)

📡 Get AI alerts when MOLBIO files next

💡 Ask AI about this filing

📊 More MOLBIO filings

🔥 Also filed on 8 September 2026